

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 6.64774972 |
| 2 | microglial cell activation (GO:0001774) | 6.01313795 |
| 3 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.87406615 |
| 4 | protein neddylation (GO:0045116) | 5.72301456 |
| 5 | myelin maintenance (GO:0043217) | 5.51270847 |
| 6 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.49547859 |
| 7 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 5.44851851 |
| 8 | ensheathment of neurons (GO:0007272) | 5.35951098 |
| 9 | axon ensheathment (GO:0008366) | 5.35951098 |
| 10 | myelination (GO:0042552) | 5.35815582 |
| 11 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.21445836 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.98725592 |
| 13 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.90125837 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.59983424 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.49055000 |
| 16 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.48565149 |
| 17 | neural tube formation (GO:0001841) | 4.44594166 |
| 18 | regulation of collateral sprouting (GO:0048670) | 4.40918609 |
| 19 | hepatocyte apoptotic process (GO:0097284) | 4.40454933 |
| 20 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.40162278 |
| 21 | response to methylmercury (GO:0051597) | 4.40064020 |
| 22 | neutrophil mediated immunity (GO:0002446) | 4.36660106 |
| 23 | negative regulation of neurotransmitter transport (GO:0051589) | 4.33230948 |
| 24 | positive regulation of response to oxidative stress (GO:1902884) | 4.30798791 |
| 25 | positive regulation of cellular response to oxidative stress (GO:1900409) | 4.30798791 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.27884018 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.27884018 |
| 28 | histone mRNA catabolic process (GO:0071044) | 4.25972949 |
| 29 | myeloid leukocyte mediated immunity (GO:0002444) | 4.22467786 |
| 30 | protein targeting to Golgi (GO:0000042) | 4.21908967 |
| 31 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 4.19233632 |
| 32 | positive regulation of receptor recycling (GO:0001921) | 4.18877669 |
| 33 | establishment of protein localization to Golgi (GO:0072600) | 4.15274121 |
| 34 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 4.11738724 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.10240169 |
| 36 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.04030271 |
| 37 | negative regulation of protein localization to cell surface (GO:2000009) | 4.01672468 |
| 38 | regulation of beta-amyloid formation (GO:1902003) | 3.98864928 |
| 39 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.93277570 |
| 40 | microtubule polymerization or depolymerization (GO:0031109) | 3.81966965 |
| 41 | activated T cell proliferation (GO:0050798) | 3.79384312 |
| 42 | positive regulation of mitochondrial fission (GO:0090141) | 3.79092133 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.77202240 |
| 44 | macrophage activation (GO:0042116) | 3.72095037 |
| 45 | dopamine transport (GO:0015872) | 3.66935000 |
| 46 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.65584286 |
| 47 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.64192438 |
| 48 | presynaptic membrane organization (GO:0097090) | 3.63559999 |
| 49 | cellular response to epinephrine stimulus (GO:0071872) | 3.63519829 |
| 50 | oligodendrocyte differentiation (GO:0048709) | 3.62765155 |
| 51 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.60325302 |
| 52 | response to redox state (GO:0051775) | 3.58635701 |
| 53 | cholesterol biosynthetic process (GO:0006695) | 3.54836099 |
| 54 | chaperone-mediated protein transport (GO:0072321) | 3.53249415 |
| 55 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.51368121 |
| 56 | apical protein localization (GO:0045176) | 3.48995397 |
| 57 | protein K48-linked deubiquitination (GO:0071108) | 3.48357878 |
| 58 | eye photoreceptor cell differentiation (GO:0001754) | 3.47960014 |
| 59 | photoreceptor cell differentiation (GO:0046530) | 3.47960014 |
| 60 | response to lead ion (GO:0010288) | 3.47364675 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 3.46875822 |
| 62 | histone H3-K36 demethylation (GO:0070544) | 3.45805891 |
| 63 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.41900909 |
| 64 | asymmetric protein localization (GO:0008105) | 3.41702360 |
| 65 | dosage compensation (GO:0007549) | 3.41572601 |
| 66 | substantia nigra development (GO:0021762) | 3.40875602 |
| 67 | cellular response to leptin stimulus (GO:0044320) | 3.38890964 |
| 68 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.38091568 |
| 69 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.38091568 |
| 70 | amyloid precursor protein metabolic process (GO:0042982) | 3.35850904 |
| 71 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35196672 |
| 72 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35196672 |
| 73 | modulation by symbiont of host immune response (GO:0052553) | 3.35196672 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35196672 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 3.35196672 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35196672 |
| 77 | neurotransmitter uptake (GO:0001504) | 3.33609594 |
| 78 | isoprenoid biosynthetic process (GO:0008299) | 3.33268851 |
| 79 | regulation of mitochondrial depolarization (GO:0051900) | 3.32926768 |
| 80 | regulation of mitochondrial fission (GO:0090140) | 3.31184534 |
| 81 | creatine metabolic process (GO:0006600) | 3.30351445 |
| 82 | protein K63-linked deubiquitination (GO:0070536) | 3.30060904 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29024555 |
| 84 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.26861202 |
| 85 | peptidyl-cysteine modification (GO:0018198) | 3.26439803 |
| 86 | import into cell (GO:0098657) | 3.25108795 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24298348 |
| 88 | proteasome assembly (GO:0043248) | 3.24006851 |
| 89 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22279059 |
| 90 | negative regulation of B cell proliferation (GO:0030889) | 3.22116387 |
| 91 | negative regulation of B cell mediated immunity (GO:0002713) | 3.21888787 |
| 92 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.21888787 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21212796 |
| 94 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.21121670 |
| 95 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.18992672 |
| 96 | presynaptic membrane assembly (GO:0097105) | 3.18845827 |
| 97 | response to insecticide (GO:0017085) | 3.18788878 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17843170 |
| 99 | positive regulation of pseudopodium assembly (GO:0031274) | 3.15833159 |
| 100 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.15251015 |
| 101 | negative T cell selection (GO:0043383) | 3.15111161 |
| 102 | regulation of glutamate secretion (GO:0014048) | 3.15030217 |
| 103 | negative regulation of glial cell proliferation (GO:0060253) | 3.11051181 |
| 104 | histone H3-K9 demethylation (GO:0033169) | 3.10807140 |
| 105 | negative regulation of exocytosis (GO:0045920) | 3.10050198 |
| 106 | positive T cell selection (GO:0043368) | 3.09952927 |
| 107 | GPI anchor biosynthetic process (GO:0006506) | 3.05680541 |
| 108 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.05633963 |
| 109 | dopamine biosynthetic process (GO:0042416) | 3.05469823 |
| 110 | olfactory bulb development (GO:0021772) | 3.04532783 |
| 111 | negative regulation of protein oligomerization (GO:0032460) | 3.03709221 |
| 112 | limb bud formation (GO:0060174) | 3.03334871 |
| 113 | astrocyte development (GO:0014002) | 3.03287128 |
| 114 | regulation of glial cell proliferation (GO:0060251) | 3.02932611 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02863098 |
| 116 | sterol biosynthetic process (GO:0016126) | 3.00294211 |
| 117 | negative regulation of complement activation (GO:0045916) | 2.99610166 |
| 118 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.99542397 |
| 119 | glycosylceramide metabolic process (GO:0006677) | 2.97463217 |
| 120 | magnesium ion transport (GO:0015693) | 2.95342442 |
| 121 | regulation of protein glycosylation (GO:0060049) | 2.95331895 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.95048681 |
| 123 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94992179 |
| 124 | protein targeting to lysosome (GO:0006622) | 2.94929414 |
| 125 | establishment of protein localization to vacuole (GO:0072666) | 2.94929414 |
| 126 | protein targeting to vacuole (GO:0006623) | 2.94929414 |
| 127 | establishment of nucleus localization (GO:0040023) | 2.94744590 |
| 128 | tissue regeneration (GO:0042246) | 2.94416188 |
| 129 | heme biosynthetic process (GO:0006783) | 2.92518322 |
| 130 | establishment of mitochondrion localization (GO:0051654) | 2.92467566 |
| 131 | synaptic vesicle endocytosis (GO:0048488) | 2.92172000 |
| 132 | hemoglobin metabolic process (GO:0020027) | 2.91165830 |
| 133 | cellular extravasation (GO:0045123) | 2.90758545 |
| 134 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.89993096 |
| 135 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.89761815 |
| 136 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88129156 |
| 137 | regulation of receptor recycling (GO:0001919) | 2.87808435 |
| 138 | protein localization to Golgi apparatus (GO:0034067) | 2.87719298 |
| 139 | histone H3-K4 trimethylation (GO:0080182) | 2.87587991 |
| 140 | cellular response to catecholamine stimulus (GO:0071870) | 2.85800905 |
| 141 | cellular response to monoamine stimulus (GO:0071868) | 2.85800905 |
| 142 | negative regulation of inclusion body assembly (GO:0090084) | 2.85770852 |
| 143 | histone H2B ubiquitination (GO:0033523) | 2.85273778 |
| 144 | phospholipid homeostasis (GO:0055091) | 2.84776105 |
| 145 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.84598338 |
| 146 | response to epinephrine (GO:0071871) | 2.84313499 |
| 147 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.82138390 |
| 148 | macroautophagy (GO:0016236) | 2.81356612 |
| 149 | regulation of cellular amide metabolic process (GO:0034248) | 2.80742519 |
| 150 | detection of external biotic stimulus (GO:0098581) | 2.78607252 |
| 151 | L-amino acid import (GO:0043092) | 2.77867008 |
| 152 | GPI anchor metabolic process (GO:0006505) | 2.77217447 |
| 153 | regulation of interleukin-13 production (GO:0032656) | 2.77115160 |
| 154 | macrophage activation involved in immune response (GO:0002281) | 2.77019112 |
| 155 | negative regulation of JUN kinase activity (GO:0043508) | 2.75917419 |
| 156 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75903332 |
| 157 | membrane raft organization (GO:0031579) | 2.75276305 |
| 158 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.74382943 |
| 159 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.73915472 |
| 160 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73442083 |
| 161 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.72744149 |
| 162 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.72220817 |
| 163 | cellular response to ethanol (GO:0071361) | 2.71785059 |
| 164 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.70907003 |
| 165 | enteric nervous system development (GO:0048484) | 2.70733325 |
| 166 | * mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.68932429 |
| 167 | * positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.68932429 |
| 168 | virion attachment to host cell (GO:0019062) | 2.65211251 |
| 169 | adhesion of symbiont to host cell (GO:0044650) | 2.65211251 |
| 170 | protein K11-linked deubiquitination (GO:0035871) | 2.64708187 |
| 171 | regulation of pseudopodium assembly (GO:0031272) | 2.64161878 |
| 172 | response to lipoprotein particle (GO:0055094) | 2.62894866 |
| 173 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.62233441 |
| 174 | regulation of exit from mitosis (GO:0007096) | 2.60420185 |
| 175 | glial cell development (GO:0021782) | 2.59736728 |
| 176 | cellular response to gamma radiation (GO:0071480) | 2.59571923 |
| 177 | iron coordination entity transport (GO:1901678) | 2.56445048 |
| 178 | neurotransmitter catabolic process (GO:0042135) | 2.56294591 |
| 179 | glycerophospholipid catabolic process (GO:0046475) | 2.53608957 |
| 180 | lung-associated mesenchyme development (GO:0060484) | 2.53361269 |
| 181 | mesodermal cell differentiation (GO:0048333) | 2.52160851 |
| 182 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.51453824 |
| 183 | termination of RNA polymerase III transcription (GO:0006386) | 2.51453824 |
| 184 | heme metabolic process (GO:0042168) | 2.50380873 |
| 185 | RNA capping (GO:0036260) | 2.46082688 |
| 186 | 7-methylguanosine RNA capping (GO:0009452) | 2.46082688 |
| 187 | neutrophil activation involved in immune response (GO:0002283) | 2.44883291 |
| 188 | 7-methylguanosine mRNA capping (GO:0006370) | 2.44393086 |
| 189 | membrane tubulation (GO:0097320) | 2.42071365 |
| 190 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.41226847 |
| 191 | oligodendrocyte development (GO:0014003) | 2.38954688 |
| 192 | positive regulation of actin filament depolymerization (GO:0030836) | 2.38462047 |
| 193 | tetrapyrrole biosynthetic process (GO:0033014) | 2.37651431 |
| 194 | axon development (GO:0061564) | 2.37157605 |
| 195 | negative regulation of acute inflammatory response (GO:0002674) | 2.36967937 |
| 196 | axon ensheathment in central nervous system (GO:0032291) | 10.0679994 |
| 197 | central nervous system myelination (GO:0022010) | 10.0679994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.38062775 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.23553552 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.14464598 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.14596479 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.95165155 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.78653528 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55557621 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.50675745 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50530014 |
| 10 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.49878676 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.47992011 |
| 12 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.41000060 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.37749902 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.35834295 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.22584708 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20798262 |
| 17 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.17113423 |
| 18 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10422559 |
| 19 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.09013028 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.04739123 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97336233 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.96493106 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92565969 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91416173 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.89965035 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.89923024 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88524671 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84770739 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84215892 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84074078 |
| 31 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.83854874 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83786553 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82688740 |
| 34 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.76440686 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75581387 |
| 36 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.72069235 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71958329 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67481841 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65067321 |
| 40 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.64297154 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.61525493 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60887732 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60688732 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58213418 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.57840644 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54858762 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54704329 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54704329 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54384636 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54000282 |
| 51 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53554737 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52358851 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51679683 |
| 54 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49491148 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46491323 |
| 56 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.46419755 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45217275 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.42924920 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42244612 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.40371908 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39459128 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.38886584 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38602620 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37156138 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36618808 |
| 66 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.36530395 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36365086 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36069959 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35650878 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35308876 |
| 71 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34986901 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33448537 |
| 73 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33331620 |
| 74 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.30758028 |
| 75 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.28010997 |
| 76 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.27438673 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.26307383 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26182964 |
| 79 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24843707 |
| 80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24600214 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24542361 |
| 82 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24091544 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23610240 |
| 84 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.22878313 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22848219 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22848219 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21644811 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.21256703 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21229333 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21110555 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20562511 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20551869 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19506494 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19400371 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.19255638 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19209329 |
| 97 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19209329 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19024672 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18330122 |
| 100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17830985 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17053539 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16797889 |
| 103 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.16684042 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13913454 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13754574 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13495821 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13022770 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12946396 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12089137 |
| 110 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10452470 |
| 111 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10132190 |
| 112 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.10132190 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09895283 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09883662 |
| 115 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09759270 |
| 116 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.09708881 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08418367 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08062242 |
| 119 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08030938 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07728286 |
| 121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07704462 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07615074 |
| 123 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07306020 |
| 124 | * MYB_26560356_Chip-Seq_TH2_Human | 1.07144478 |
| 125 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07050277 |
| 126 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06530934 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06177901 |
| 128 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05854139 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05706257 |
| 130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05081356 |
| 131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05069147 |
| 132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04875382 |
| 133 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.03750188 |
| 134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03591868 |
| 135 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03506358 |
| 136 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02906830 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01086044 |
| 138 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01082384 |
| 139 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00742382 |
| 140 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.98295471 |
| 141 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97970197 |
| 142 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97712036 |
| 143 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96668800 |
| 144 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95864550 |
| 145 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95078632 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93843172 |
| 147 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93384404 |
| 148 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.93132134 |
| 149 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92842738 |
| 150 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92128109 |
| 151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91815339 |
| 152 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90966898 |
| 153 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89978732 |
| 154 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89474194 |
| 155 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88115551 |
| 156 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87301874 |
| 157 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.87059158 |
| 158 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85935121 |
| 159 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85812539 |
| 160 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85687743 |
| 161 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85434197 |
| 162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84618003 |
| 163 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84323041 |
| 164 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83039746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 8.14792994 |
| 2 | MP0003787_abnormal_imprinting | 5.07467265 |
| 3 | MP0004147_increased_porphyrin_level | 5.03848135 |
| 4 | MP0000920_abnormal_myelination | 4.65545916 |
| 5 | MP0003950_abnormal_plasma_membrane | 4.21657711 |
| 6 | MP0003880_abnormal_central_pattern | 3.54495013 |
| 7 | * MP0003656_abnormal_erythrocyte_physiolo | 2.93600458 |
| 8 | MP0001529_abnormal_vocalization | 2.84358669 |
| 9 | MP0003122_maternal_imprinting | 2.82842703 |
| 10 | MP0004883_abnormal_blood_vessel | 2.71133889 |
| 11 | MP0001905_abnormal_dopamine_level | 2.66573396 |
| 12 | MP0005171_absent_coat_pigmentation | 2.60596435 |
| 13 | MP0003136_yellow_coat_color | 2.58755253 |
| 14 | MP0001346_abnormal_lacrimal_gland | 2.54480267 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.45160928 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.36263494 |
| 17 | MP0003690_abnormal_glial_cell | 2.28133848 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.26736579 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.19452719 |
| 20 | MP0000383_abnormal_hair_follicle | 2.17046510 |
| 21 | MP0002009_preneoplasia | 2.16694123 |
| 22 | MP0005187_abnormal_penis_morphology | 2.12881901 |
| 23 | MP0004742_abnormal_vestibular_system | 2.12277227 |
| 24 | MP0004885_abnormal_endolymph | 2.10855211 |
| 25 | * MP0008260_abnormal_autophagy | 1.98671728 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.90006528 |
| 27 | MP0001485_abnormal_pinna_reflex | 1.89373545 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.86324932 |
| 29 | MP0003303_peritoneal_inflammation | 1.77333215 |
| 30 | MP0004270_analgesia | 1.77227828 |
| 31 | MP0002272_abnormal_nervous_system | 1.73161110 |
| 32 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.72798220 |
| 33 | MP0003634_abnormal_glial_cell | 1.66847595 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.66672411 |
| 35 | MP0000647_abnormal_sebaceous_gland | 1.63908575 |
| 36 | MP0004381_abnormal_hair_follicle | 1.63153926 |
| 37 | MP0008995_early_reproductive_senescence | 1.60036692 |
| 38 | MP0005164_abnormal_response_to | 1.58481061 |
| 39 | MP0005451_abnormal_body_composition | 1.53601340 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.53277536 |
| 41 | MP0001958_emphysema | 1.52616791 |
| 42 | MP0000778_abnormal_nervous_system | 1.52297996 |
| 43 | MP0003329_amyloid_beta_deposits | 1.50747066 |
| 44 | MP0001851_eye_inflammation | 1.50074494 |
| 45 | MP0001661_extended_life_span | 1.49443262 |
| 46 | MP0008057_abnormal_DNA_replication | 1.48974067 |
| 47 | MP0002938_white_spotting | 1.44261233 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.37048690 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.36348537 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.35911174 |
| 51 | MP0005408_hypopigmentation | 1.35826375 |
| 52 | MP0006082_CNS_inflammation | 1.33050117 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.30571501 |
| 54 | MP0001486_abnormal_startle_reflex | 1.30193476 |
| 55 | MP0003828_pulmonary_edema | 1.29751036 |
| 56 | MP0003938_abnormal_ear_development | 1.27719525 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.27132132 |
| 58 | MP0001800_abnormal_humoral_immune | 1.25483255 |
| 59 | MP0003632_abnormal_nervous_system | 1.25204603 |
| 60 | MP0005409_darkened_coat_color | 1.24804387 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.23978537 |
| 62 | MP0002064_seizures | 1.23031351 |
| 63 | MP0000566_synostosis | 1.21092587 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.19977677 |
| 65 | MP0002229_neurodegeneration | 1.19899051 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.19280389 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.18938090 |
| 68 | MP0001963_abnormal_hearing_physiology | 1.17991865 |
| 69 | MP0002928_abnormal_bile_duct | 1.17506904 |
| 70 | MP0003123_paternal_imprinting | 1.15436259 |
| 71 | MP0003091_abnormal_cell_migration | 1.11814953 |
| 72 | MP0003186_abnormal_redox_activity | 1.08195238 |
| 73 | MP0003718_maternal_effect | 1.06691232 |
| 74 | MP0002419_abnormal_innate_immunity | 1.06098213 |
| 75 | MP0005671_abnormal_response_to | 1.05606594 |
| 76 | MP0000579_abnormal_nail_morphology | 1.05206095 |
| 77 | MP0004130_abnormal_muscle_cell | 1.04017989 |
| 78 | MP0003937_abnormal_limbs/digits/tail_de | 1.03542924 |
| 79 | * MP0004484_altered_response_of | 1.01400546 |
| 80 | MP0005195_abnormal_posterior_eye | 1.00415951 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.99912709 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.98736357 |
| 83 | MP0000371_diluted_coat_color | 0.96716582 |
| 84 | * MP0000689_abnormal_spleen_morphology | 0.96155585 |
| 85 | MP0000762_abnormal_tongue_morphology | 0.95464976 |
| 86 | MP0003195_calcinosis | 0.95017286 |
| 87 | MP0002405_respiratory_system_inflammati | 0.94919542 |
| 88 | MP0004811_abnormal_neuron_physiology | 0.92748633 |
| 89 | MP0004134_abnormal_chest_morphology | 0.92222844 |
| 90 | MP0004142_abnormal_muscle_tone | 0.92155090 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.91336458 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.91336458 |
| 93 | MP0000685_abnormal_immune_system | 0.91333554 |
| 94 | MP0003121_genomic_imprinting | 0.90972382 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.89446337 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.89430117 |
| 97 | MP0005253_abnormal_eye_physiology | 0.88907497 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.88735829 |
| 99 | MP0003631_nervous_system_phenotype | 0.88695584 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.88430204 |
| 101 | MP0001984_abnormal_olfaction | 0.87632974 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.86848129 |
| 103 | * MP0002398_abnormal_bone_marrow | 0.86240214 |
| 104 | MP0002723_abnormal_immune_serum | 0.85935632 |
| 105 | MP0001542_abnormal_bone_strength | 0.85714794 |
| 106 | MP0002133_abnormal_respiratory_system | 0.85529478 |
| 107 | MP0005388_respiratory_system_phenotype | 0.85529478 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.84763858 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.84221324 |
| 110 | MP0001819_abnormal_immune_cell | 0.83891652 |
| 111 | MP0006054_spinal_hemorrhage | 0.83109810 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.82842037 |
| 113 | * MP0002722_abnormal_immune_system | 0.82751218 |
| 114 | MP0000026_abnormal_inner_ear | 0.82205825 |
| 115 | MP0002736_abnormal_nociception_after | 0.82130524 |
| 116 | MP0001188_hyperpigmentation | 0.81579923 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.81530949 |
| 118 | MP0005367_renal/urinary_system_phenotyp | 0.80136193 |
| 119 | MP0000516_abnormal_urinary_system | 0.80136193 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.80131557 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.78604353 |
| 122 | MP0000716_abnormal_immune_system | 0.78567876 |
| 123 | MP0001177_atelectasis | 0.78231667 |
| 124 | MP0002882_abnormal_neuron_morphology | 0.77407252 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.77124523 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.76652339 |
| 127 | MP0001970_abnormal_pain_threshold | 0.76005486 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.75799716 |
| 129 | MP0006292_abnormal_olfactory_placode | 0.75469351 |
| 130 | MP0005025_abnormal_response_to | 0.73627669 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.73626419 |
| 132 | MP0000427_abnormal_hair_cycle | 0.73481827 |
| 133 | MP0005310_abnormal_salivary_gland | 0.72987854 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.72619339 |
| 135 | MP0003724_increased_susceptibility_to | 0.71101655 |
| 136 | MP0009785_altered_susceptibility_to | 0.71003954 |
| 137 | MP0002090_abnormal_vision | 0.70256919 |
| 138 | MP0001915_intracranial_hemorrhage | 0.70004983 |
| 139 | MP0008874_decreased_physiological_sensi | 0.69990114 |
| 140 | MP0002102_abnormal_ear_morphology | 0.69667531 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.69637912 |
| 142 | MP0008569_lethality_at_weaning | 0.69413268 |
| 143 | MP0003633_abnormal_nervous_system | 0.69331260 |
| 144 | MP0002971_abnormal_brown_adipose | 0.69303685 |
| 145 | MP0002653_abnormal_ependyma_morphology | 0.69061226 |
| 146 | MP0003879_abnormal_hair_cell | 0.68830167 |
| 147 | MP0001879_abnormal_lymphatic_vessel | 0.68437844 |
| 148 | MP0009046_muscle_twitch | 0.67089622 |
| 149 | MP0002066_abnormal_motor_capabilities/c | 0.66635729 |
| 150 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66545471 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.65855536 |
| 152 | MP0000537_abnormal_urethra_morphology | 0.64365770 |
| 153 | MP0005266_abnormal_metabolism | 0.63574186 |
| 154 | MP0008775_abnormal_heart_ventricle | 0.62980800 |
| 155 | MP0009764_decreased_sensitivity_to | 0.62748692 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.62226475 |
| 157 | MP0001440_abnormal_grooming_behavior | 0.62093634 |
| 158 | MP0002638_abnormal_pupillary_reflex | 0.61900931 |
| 159 | MP0002006_tumorigenesis | 0.61499049 |
| 160 | MP0004272_abnormal_basement_membrane | 0.61333320 |
| 161 | MP0000604_amyloidosis | 0.60923906 |
| 162 | MP0001968_abnormal_touch/_nociception | 0.60807804 |
| 163 | MP0004036_abnormal_muscle_relaxation | 0.60737584 |
| 164 | MP0005391_vision/eye_phenotype | 0.59904849 |
| 165 | MP0003635_abnormal_synaptic_transmissio | 0.59848619 |
| 166 | MP0003453_abnormal_keratinocyte_physiol | 0.59637987 |
| 167 | MP0000249_abnormal_blood_vessel | 0.59435362 |
| 168 | MP0002063_abnormal_learning/memory/cond | 0.57798505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 7.27204363 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.02404980 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.02404980 |
| 4 | Cerebral hypomyelination (HP:0006808) | 4.99206439 |
| 5 | T lymphocytopenia (HP:0005403) | 4.85782224 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.55099522 |
| 7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.46663567 |
| 8 | Increased serum pyruvate (HP:0003542) | 4.43876251 |
| 9 | Abnormality of glycolysis (HP:0004366) | 4.43876251 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.37205670 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.35267739 |
| 12 | Papillary thyroid carcinoma (HP:0002895) | 4.35171714 |
| 13 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.21041440 |
| 14 | Postural instability (HP:0002172) | 4.04914611 |
| 15 | Visual hallucinations (HP:0002367) | 3.99665207 |
| 16 | Parakeratosis (HP:0001036) | 3.89915059 |
| 17 | Peritonitis (HP:0002586) | 3.58975879 |
| 18 | Abnormal auditory evoked potentials (HP:0006958) | 3.56840639 |
| 19 | Sensory axonal neuropathy (HP:0003390) | 3.55371385 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 3.52703434 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.49832349 |
| 22 | Gingival bleeding (HP:0000225) | 3.49407073 |
| 23 | Peripheral hypomyelination (HP:0007182) | 3.47259691 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.36664149 |
| 25 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.36624807 |
| 26 | Abnormality of the corticospinal tract (HP:0002492) | 3.29637920 |
| 27 | CNS hypomyelination (HP:0003429) | 3.25348704 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.18104579 |
| 29 | Paralysis (HP:0003470) | 3.16324172 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.16053945 |
| 31 | Stenosis of the external auditory canal (HP:0000402) | 3.08449575 |
| 32 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.07284796 |
| 33 | Prolonged neonatal jaundice (HP:0006579) | 3.04421610 |
| 34 | Subacute progressive viral hepatitis (HP:0006572) | 2.99761342 |
| 35 | Optic neuritis (HP:0100653) | 2.99309174 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.99309174 |
| 37 | Conjunctival telangiectasia (HP:0000524) | 2.98849483 |
| 38 | Thickened helices (HP:0000391) | 2.93922874 |
| 39 | Orthostatic hypotension (HP:0001278) | 2.88379560 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.84792545 |
| 41 | Autoamputation (HP:0001218) | 2.84185215 |
| 42 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.82747481 |
| 43 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.82747481 |
| 44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.80776385 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.79139188 |
| 46 | Onion bulb formation (HP:0003383) | 2.78988061 |
| 47 | Spastic paraparesis (HP:0002313) | 2.75914214 |
| 48 | Microcytic anemia (HP:0001935) | 2.68521231 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.67968350 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.66441131 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.65088093 |
| 52 | Resting tremor (HP:0002322) | 2.63354164 |
| 53 | Leukodystrophy (HP:0002415) | 2.61071596 |
| 54 | Amyotrophic lateral sclerosis (HP:0007354) | 2.60874571 |
| 55 | Leukocytosis (HP:0001974) | 2.60441851 |
| 56 | Febrile seizures (HP:0002373) | 2.60111836 |
| 57 | Abnormal hair whorl (HP:0010721) | 2.59917892 |
| 58 | Orchitis (HP:0100796) | 2.58351980 |
| 59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57720352 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.57195426 |
| 61 | Split foot (HP:0001839) | 2.56988513 |
| 62 | Morphological abnormality of the inner ear (HP:0011390) | 2.51042887 |
| 63 | Absent septum pellucidum (HP:0001331) | 2.48318638 |
| 64 | Recurrent skin infections (HP:0001581) | 2.47784350 |
| 65 | Clumsiness (HP:0002312) | 2.47145457 |
| 66 | Hip dysplasia (HP:0001385) | 2.46991870 |
| 67 | Thyroiditis (HP:0100646) | 2.46952081 |
| 68 | Patchy hypopigmentation of hair (HP:0011365) | 2.44651229 |
| 69 | Postnatal microcephaly (HP:0005484) | 2.41442181 |
| 70 | White forelock (HP:0002211) | 2.40649256 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.39916402 |
| 72 | Absent frontal sinuses (HP:0002688) | 2.39408041 |
| 73 | Myositis (HP:0100614) | 2.38926047 |
| 74 | Abnormality of the septum pellucidum (HP:0007375) | 2.38740271 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38311535 |
| 76 | Diaphragmatic weakness (HP:0009113) | 2.38063172 |
| 77 | Hemiplegia (HP:0002301) | 2.37724191 |
| 78 | Genetic anticipation (HP:0003743) | 2.36904128 |
| 79 | Gingivitis (HP:0000230) | 2.34122443 |
| 80 | Poor speech (HP:0002465) | 2.33685800 |
| 81 | Delusions (HP:0000746) | 2.33596934 |
| 82 | Adrenal hypoplasia (HP:0000835) | 2.30967342 |
| 83 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.29196841 |
| 84 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.29196841 |
| 85 | Single umbilical artery (HP:0001195) | 2.29196841 |
| 86 | Supranuclear gaze palsy (HP:0000605) | 2.28015942 |
| 87 | Periodontitis (HP:0000704) | 2.27825445 |
| 88 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.25303412 |
| 89 | Hyperventilation (HP:0002883) | 2.24098109 |
| 90 | Large earlobe (HP:0009748) | 2.22102772 |
| 91 | Cerebral hemorrhage (HP:0001342) | 2.21653222 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.21517957 |
| 93 | Ankle clonus (HP:0011448) | 2.20931251 |
| 94 | Termporal pattern (HP:0011008) | 2.19747018 |
| 95 | Insidious onset (HP:0003587) | 2.19747018 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.19563000 |
| 97 | Poikilocytosis (HP:0004447) | 2.18939576 |
| 98 | Palpebral edema (HP:0100540) | 2.17814828 |
| 99 | Spastic gait (HP:0002064) | 2.17255313 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.15632941 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.12983550 |
| 102 | Widely spaced teeth (HP:0000687) | 2.12581415 |
| 103 | Muscle fiber splitting (HP:0003555) | 2.11714437 |
| 104 | Cupped ear (HP:0000378) | 2.10119323 |
| 105 | Arterial thrombosis (HP:0004420) | 2.08199717 |
| 106 | Absent speech (HP:0001344) | 2.07130483 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.06113982 |
| 108 | Stomatitis (HP:0010280) | 2.05017696 |
| 109 | Acanthocytosis (HP:0001927) | 2.03084640 |
| 110 | Eosinophilia (HP:0001880) | 2.02587515 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.98299108 |
| 112 | Abnormality of the umbilical cord (HP:0010881) | 1.97978636 |
| 113 | Volvulus (HP:0002580) | 1.97871105 |
| 114 | Abnormality of eosinophils (HP:0001879) | 1.97795181 |
| 115 | Septo-optic dysplasia (HP:0100842) | 1.97283379 |
| 116 | Paraparesis (HP:0002385) | 1.96458086 |
| 117 | Axonal loss (HP:0003447) | 1.96112004 |
| 118 | Epistaxis (HP:0000421) | 1.95517933 |
| 119 | Gaze-evoked nystagmus (HP:0000640) | 1.94098609 |
| 120 | Conical tooth (HP:0000698) | 1.93615453 |
| 121 | Recurrent bronchitis (HP:0002837) | 1.92691833 |
| 122 | Drooling (HP:0002307) | 1.92519753 |
| 123 | Chest pain (HP:0100749) | 1.91507942 |
| 124 | Polyphagia (HP:0002591) | 1.90958125 |
| 125 | Abnormality of T cells (HP:0002843) | 1.89375749 |
| 126 | Excessive salivation (HP:0003781) | 1.88526234 |
| 127 | Esophageal atresia (HP:0002032) | 1.88152843 |
| 128 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.87895648 |
| 129 | Humeroradial synostosis (HP:0003041) | 1.87206271 |
| 130 | Synostosis involving the elbow (HP:0003938) | 1.87206271 |
| 131 | Vaginal atresia (HP:0000148) | 1.87043748 |
| 132 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85525100 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85525100 |
| 134 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.85493550 |
| 135 | Hypoplastic left heart (HP:0004383) | 1.85366478 |
| 136 | Bladder carcinoma (HP:0002862) | 1.85133506 |
| 137 | Bladder neoplasm (HP:0009725) | 1.85133506 |
| 138 | Increased mean platelet volume (HP:0011877) | 1.84243997 |
| 139 | Abnormal gallbladder morphology (HP:0012437) | 1.82922189 |
| 140 | Acute hepatic failure (HP:0006554) | 1.82760310 |
| 141 | Medial flaring of the eyebrow (HP:0010747) | 1.82554119 |
| 142 | Pheochromocytoma (HP:0002666) | 1.82393608 |
| 143 | Ileus (HP:0002595) | 1.81709214 |
| 144 | Corneal dystrophy (HP:0001131) | 1.81458656 |
| 145 | Cholelithiasis (HP:0001081) | 1.81452994 |
| 146 | Intention tremor (HP:0002080) | 1.81440007 |
| 147 | Truncal obesity (HP:0001956) | 1.81372848 |
| 148 | Hematochezia (HP:0002573) | 1.80990956 |
| 149 | Neuroendocrine neoplasm (HP:0100634) | 1.80567682 |
| 150 | Premature skin wrinkling (HP:0100678) | 1.80521333 |
| 151 | Glucose intolerance (HP:0000833) | 1.80191530 |
| 152 | Genital tract atresia (HP:0001827) | 1.78350105 |
| 153 | Anteriorly placed anus (HP:0001545) | 1.77273788 |
| 154 | Viral hepatitis (HP:0006562) | 1.76819329 |
| 155 | Seborrheic dermatitis (HP:0001051) | 1.76350554 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.76107964 |
| 157 | True hermaphroditism (HP:0010459) | 1.75933035 |
| 158 | Alacrima (HP:0000522) | 1.75578199 |
| 159 | Erythroderma (HP:0001019) | 1.75119239 |
| 160 | Limb dystonia (HP:0002451) | 1.74557509 |
| 161 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.74455312 |
| 162 | Abnormal platelet volume (HP:0011876) | 1.74232096 |
| 163 | Difficulty running (HP:0009046) | 1.73478977 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.72992125 |
| 165 | Gait imbalance (HP:0002141) | 1.72916090 |
| 166 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71953719 |
| 167 | Abnormal gallbladder physiology (HP:0012438) | 1.71873941 |
| 168 | Cholecystitis (HP:0001082) | 1.71873941 |
| 169 | Hypoplasia of the uterus (HP:0000013) | 1.71860417 |
| 170 | Stomach cancer (HP:0012126) | 1.71780207 |
| 171 | Congenital primary aphakia (HP:0007707) | 1.70817770 |
| 172 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70005935 |
| 173 | Congenital malformation of the right heart (HP:0011723) | 1.69752228 |
| 174 | Double outlet right ventricle (HP:0001719) | 1.69752228 |
| 175 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69191017 |
| 176 | Myokymia (HP:0002411) | 1.68503669 |
| 177 | Renal Fanconi syndrome (HP:0001994) | 1.68370350 |
| 178 | Long nose (HP:0003189) | 1.68365489 |
| 179 | Stridor (HP:0010307) | 1.68135246 |
| 180 | Pancreatic cysts (HP:0001737) | 1.67438069 |
| 181 | Dysmetria (HP:0001310) | 1.67162112 |
| 182 | Nasolacrimal duct obstruction (HP:0000579) | 1.66906485 |
| 183 | Abnormality of the labia minora (HP:0012880) | 1.66798795 |
| 184 | Scanning speech (HP:0002168) | 1.66490535 |
| 185 | Cutaneous photosensitivity (HP:0000992) | 1.66171163 |
| 186 | Hypoplastic pelvis (HP:0008839) | 1.63379832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.89128153 |
| 2 | OXSR1 | 3.90089072 |
| 3 | PBK | 3.62005846 |
| 4 | BCR | 3.17049352 |
| 5 | CASK | 3.04001321 |
| 6 | GRK6 | 2.79792718 |
| 7 | CDK19 | 2.63664754 |
| 8 | MAPKAPK5 | 2.58372026 |
| 9 | FRK | 2.56965486 |
| 10 | LIMK1 | 2.42423660 |
| 11 | SGK2 | 2.42411890 |
| 12 | BUB1 | 2.25619564 |
| 13 | RIPK4 | 2.20844514 |
| 14 | CSNK1G3 | 2.18805101 |
| 15 | PKN1 | 1.99327836 |
| 16 | EPHB1 | 1.98036154 |
| 17 | FGFR2 | 1.95109857 |
| 18 | IKBKE | 1.94467818 |
| 19 | CSNK1A1L | 1.90037962 |
| 20 | MST4 | 1.86414020 |
| 21 | BLK | 1.83429822 |
| 22 | EIF2AK1 | 1.78851718 |
| 23 | NEK6 | 1.76965719 |
| 24 | SGK494 | 1.74994854 |
| 25 | SGK223 | 1.74994854 |
| 26 | DYRK2 | 1.71862207 |
| 27 | CAMKK2 | 1.71237567 |
| 28 | ARAF | 1.69158667 |
| 29 | CSNK1G1 | 1.67355397 |
| 30 | EPHA3 | 1.67112911 |
| 31 | TAOK3 | 1.61181231 |
| 32 | KSR1 | 1.60782790 |
| 33 | ERBB2 | 1.60427082 |
| 34 | SGK3 | 1.60224468 |
| 35 | MET | 1.59750252 |
| 36 | MAP3K4 | 1.59332744 |
| 37 | STK16 | 1.52933621 |
| 38 | CSNK1G2 | 1.51154908 |
| 39 | MKNK1 | 1.47024568 |
| 40 | CSK | 1.44812112 |
| 41 | FGFR3 | 1.40998645 |
| 42 | PAK3 | 1.40363068 |
| 43 | WNK4 | 1.37831586 |
| 44 | MAP4K2 | 1.33244850 |
| 45 | TSSK6 | 1.32166508 |
| 46 | PLK2 | 1.31688034 |
| 47 | NLK | 1.31168774 |
| 48 | SYK | 1.30297650 |
| 49 | CAMK2B | 1.30065432 |
| 50 | MAP3K2 | 1.29491321 |
| 51 | DYRK3 | 1.25999969 |
| 52 | PIK3CG | 1.25428631 |
| 53 | TRIM28 | 1.23810255 |
| 54 | AKT3 | 1.14431594 |
| 55 | BMPR1B | 1.14309446 |
| 56 | JAK3 | 1.13936681 |
| 57 | FES | 1.13440792 |
| 58 | CLK1 | 1.13225480 |
| 59 | MAP2K3 | 1.12689789 |
| 60 | ROCK2 | 1.10471669 |
| 61 | IRAK1 | 1.07730829 |
| 62 | PNCK | 1.05677360 |
| 63 | TRPM7 | 1.05605161 |
| 64 | MAP3K12 | 1.04918215 |
| 65 | TXK | 1.04075261 |
| 66 | MAP3K6 | 1.01926893 |
| 67 | JAK1 | 1.00538858 |
| 68 | FGR | 1.00503886 |
| 69 | PIM1 | 0.98765610 |
| 70 | MAP2K4 | 0.94322239 |
| 71 | ERBB3 | 0.93378609 |
| 72 | PLK3 | 0.92214001 |
| 73 | RPS6KA5 | 0.91487370 |
| 74 | MAP3K5 | 0.90906667 |
| 75 | PRPF4B | 0.87842817 |
| 76 | JAK2 | 0.86446226 |
| 77 | CDK14 | 0.85031624 |
| 78 | DYRK1B | 0.84242779 |
| 79 | STK4 | 0.83860201 |
| 80 | TYK2 | 0.82795789 |
| 81 | HCK | 0.82547738 |
| 82 | MARK2 | 0.82527467 |
| 83 | PLK4 | 0.82028329 |
| 84 | ZAK | 0.78082288 |
| 85 | PDK2 | 0.77916388 |
| 86 | CAMK2D | 0.77763023 |
| 87 | MARK1 | 0.76239813 |
| 88 | TEC | 0.75801528 |
| 89 | SGK1 | 0.75622307 |
| 90 | LYN | 0.75431853 |
| 91 | STK38 | 0.74017427 |
| 92 | WNK1 | 0.73663914 |
| 93 | ADRBK1 | 0.73209787 |
| 94 | TAOK1 | 0.73129146 |
| 95 | WNK3 | 0.72881645 |
| 96 | NUAK1 | 0.72024999 |
| 97 | MELK | 0.71853397 |
| 98 | DYRK1A | 0.71301403 |
| 99 | CAMK2G | 0.70298360 |
| 100 | UHMK1 | 0.70261929 |
| 101 | EGFR | 0.70189737 |
| 102 | STK11 | 0.69982040 |
| 103 | VRK1 | 0.69974775 |
| 104 | MARK3 | 0.69550407 |
| 105 | CAMK4 | 0.68883368 |
| 106 | BRAF | 0.68325234 |
| 107 | BTK | 0.68168852 |
| 108 | NTRK3 | 0.68080583 |
| 109 | RAF1 | 0.67716121 |
| 110 | MKNK2 | 0.67653142 |
| 111 | TIE1 | 0.65922612 |
| 112 | EPHA4 | 0.65193963 |
| 113 | OBSCN | 0.64829990 |
| 114 | PRKCE | 0.64709426 |
| 115 | ACVR1B | 0.64618761 |
| 116 | CDK3 | 0.63287948 |
| 117 | TGFBR2 | 0.63160715 |
| 118 | MAP2K7 | 0.61259600 |
| 119 | SRPK1 | 0.60441505 |
| 120 | BRD4 | 0.59291419 |
| 121 | MATK | 0.58866568 |
| 122 | BRSK2 | 0.56875097 |
| 123 | PKN2 | 0.54480600 |
| 124 | CDK18 | 0.54347547 |
| 125 | MAP3K14 | 0.54284806 |
| 126 | MAP3K1 | 0.54226316 |
| 127 | GRK5 | 0.54029726 |
| 128 | CDK15 | 0.52529522 |
| 129 | NTRK2 | 0.50258910 |
| 130 | PRKCQ | 0.50049795 |
| 131 | NTRK1 | 0.49739294 |
| 132 | STK3 | 0.49650797 |
| 133 | RET | 0.48572604 |
| 134 | CDK11A | 0.48335484 |
| 135 | TESK2 | 0.47823502 |
| 136 | DAPK3 | 0.47572616 |
| 137 | CAMK2A | 0.46998563 |
| 138 | CHUK | 0.46423759 |
| 139 | MAPK13 | 0.46093366 |
| 140 | NEK9 | 0.45685975 |
| 141 | TLK1 | 0.44114550 |
| 142 | MAP2K2 | 0.43738604 |
| 143 | RPS6KA4 | 0.43254445 |
| 144 | LCK | 0.43253209 |
| 145 | MUSK | 0.42252658 |
| 146 | CSNK1A1 | 0.42164369 |
| 147 | YES1 | 0.42067986 |
| 148 | KSR2 | 0.41757808 |
| 149 | GRK7 | 0.40455684 |
| 150 | PIK3CA | 0.37463754 |
| 151 | BMPR2 | 0.36537142 |
| 152 | CDK5 | 0.35920430 |
| 153 | IRAK2 | 0.35317660 |
| 154 | NME1 | 0.34803481 |
| 155 | MYLK | 0.34509583 |
| 156 | PAK1 | 0.32505403 |
| 157 | GRK1 | 0.31850447 |
| 158 | PRKACB | 0.30996658 |
| 159 | IRAK4 | 0.30009377 |
| 160 | WEE1 | 0.28945650 |
| 161 | PTK2B | 0.27799272 |
| 162 | ILK | 0.27594198 |
| 163 | TNIK | 0.27573907 |
| 164 | FGFR1 | 0.27438860 |
| 165 | ADRBK2 | 0.26768599 |
| 166 | PRKG1 | 0.26313814 |
| 167 | PINK1 | 0.25577420 |
| 168 | CSNK1D | 0.24219619 |
| 169 | ABL2 | 0.22941403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.90167578 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.40260001 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.17157149 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.09276864 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.97877178 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.82387999 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.70493648 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.55280500 |
| 9 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.32875619 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.28953689 |
| 11 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.23010846 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.21288228 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14946993 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06975768 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05372798 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98011838 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.88160078 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.85107344 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.79325432 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75883705 |
| 21 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.72602453 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64676981 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62083019 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.59968979 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59160708 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57974330 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56830847 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51999500 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48677058 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47318325 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.46146525 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.45481125 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.44993263 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40112301 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38568660 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.37604486 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36688002 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36632614 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36211616 |
| 40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.35972664 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.34714852 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32559250 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.31987044 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.27131522 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.22464073 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20439374 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20276489 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.17312760 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15943784 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14280357 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14033961 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.13054264 |
| 53 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11720905 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11185736 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10932367 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.10258584 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09410506 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09189905 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08809880 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08394980 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07908704 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05899751 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 1.03212223 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.03086852 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02185793 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.00967558 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99365394 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97059679 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96805416 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95347724 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94950084 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.94339103 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.91761605 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91620963 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91026672 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90915543 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85585974 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84971236 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82866884 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.82453100 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82067201 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81765105 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.81427859 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80362837 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78704153 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78228947 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77681701 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76411110 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76349298 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.76027434 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75558713 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75132918 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74787349 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73160419 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72047459 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71174973 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.71019493 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.70830987 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69887162 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69744761 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69265232 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.69112648 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68832004 |
| 104 | Phototransduction_Homo sapiens_hsa04744 | 0.68618547 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68389815 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67439587 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67378033 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.66821295 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66321412 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65140641 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64706159 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64162714 |
| 113 | Morphine addiction_Homo sapiens_hsa05032 | 0.63014604 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.63014310 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62250188 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61092970 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60614734 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60438349 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60193229 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.60104198 |
| 121 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58558139 |
| 122 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58539830 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58360535 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58242646 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58161512 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57476261 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.57103697 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56349459 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.55542175 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55389567 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54728040 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54164904 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.54103929 |
| 134 | Long-term depression_Homo sapiens_hsa04730 | 0.53818458 |
| 135 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52564675 |
| 136 | Ribosome_Homo sapiens_hsa03010 | 0.52511770 |
| 137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52380846 |
| 138 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51826754 |
| 139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.51756135 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49541248 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46941997 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44849678 |
| 143 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44313995 |
| 144 | Spliceosome_Homo sapiens_hsa03040 | 0.42399576 |
| 145 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42324588 |
| 146 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41947434 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.40305372 |
| 148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40173049 |
| 149 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38888269 |
| 150 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38348164 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.37889436 |
| 152 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37866827 |
| 153 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37798002 |
| 154 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37228376 |
| 155 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35887145 |
| 156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35638025 |
| 157 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35203430 |
| 158 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33045177 |
| 159 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32865144 |
| 160 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32834453 |
| 161 | RNA degradation_Homo sapiens_hsa03018 | 0.32008719 |
| 162 | RNA transport_Homo sapiens_hsa03013 | 0.31651558 |
| 163 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29906656 |
| 164 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29493246 |
| 165 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28754341 |
| 166 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28656937 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28656561 |
| 168 | Shigellosis_Homo sapiens_hsa05131 | 0.27749457 |
| 169 | Melanoma_Homo sapiens_hsa05218 | 0.26874456 |
| 170 | Allograft rejection_Homo sapiens_hsa05330 | 0.25887301 |
| 171 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24487430 |
| 172 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24244053 |
| 173 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23762939 |
| 174 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23610018 |
| 175 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22869901 |

